Stocks That Hit 52-Week Lows On Monday

 

Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows.

Interesting Highlights:

  • The largest company by market cap to set a new 52-week low was Ionis Pharmaceuticals IONS.
  • The smallest company by market cap to hit a new 52-week low was Millendo Therapeutics MLND.
  • Qualigen Therapeutics QLGN's stock dropped the most, trading down 14.23% to reach a new 52-week low.

During the first half-hour of trading on Monday, the following stocks set new 52-week lows:

  • Ionis Pharmaceuticals IONS stock set a new 52-week low of $41.19 on Monday, moving down 2.14%.
  • Sarepta Therapeutics SRPT stock set a new 52-week low of $68.51 on Monday, moving down 1.74%.
  • Nikola NKLA stock dropped to a yearly low on Monday of $12.02. Shares traded down 3.36%.
  • ACADIA Pharmaceuticals ACAD shares reached a new 52-week low of $20.13 on Monday morning, moving up 0.12%.
  • Reata Pharmaceuticals RETA shares moved down 2.02% on Monday to hit a new 52-week low of $86.00, drifting down 2.02%.
  • Telecom Argentina TEO stock hit $5.20 on Monday morning, setting a new 52-week low for a change of up 0.38%.
  • Axsome Therapeutics AXSM stock achieved a new 52-week low on Monday morning, hitting $51.55 and moving down 2.02%.
  • Coherus BioSciences CHRS shares fell to $13.69 on Monday, setting a new 52-week low with a shift of down 1.58%.
  • Adverum Biotechnologies ADVM stock set a new 52-week low of $8.90 on Monday, moving down 1.43%.
  • Vasta Platform VSTA shares made a new 52-week low of $8.73 on Monday. The stock was down 4.03% for the day.
  • BEST BEST stock hit a new 52-week low of $1.55. The stock was down 0.75% on the session.
  • Sigilon Therapeutics SGTX shares hit a yearly low of $16.74. The stock was up 0.23% on the session.
  • Atreca BCEL shares moved down 2.6% on Monday to hit a new 52-week low of $11.88, drifting down 2.6%.
  • Syros Pharmaceuticals SYRS stock achieved a new 52-week low on Monday morning, hitting $6.32 and moving down 2.14%.
  • Puxin NEW shares reached a new 52-week low of $3.38 on Monday morning, moving down 3.72%.
  • Puyi PUYI shares moved down 1.93% on Monday to hit a new 52-week low of $4.05, drifting down 1.93%.
  • Lannett LCI stock hit a new 52-week low of $4.77. The stock was down 2.52% on the session.
  • Assembly Biosciences ASMB shares were down 2.06% for the day, having made a 52-week low of $4.20.
  • Calithera Biosciences CALA stock drifted down 3.06% on Monday morning to hit a new 52-week low of $2.23.
  • ContraFect CFRX stock drifted down 1.43% on Monday morning to hit a new 52-week low of $4.04.
  • NeuBase Therapeutics NBSE shares hit a yearly low of $6.17. The stock was down 0.92% on the session.
  • Concert Pharmaceuticals CNCE stock achieved a new 52-week low on Monday morning, hitting $4.45 and moving down 1.75%.
  • CooTek (Cayman) CTK shares moved down 7.48% on Monday to hit a new 52-week low of $2.31, drifting down 7.48%.
  • TD Hldgs GLG shares were down 11.88% for the day, having made a 52-week low of $1.34.
  • Metacrine MTCR shares fell to $5.10 on Monday, setting a new 52-week low with a shift of down 0.39%.
  • Imara IMRA stock hit a new 52-week low of $7.43. The stock was down 1.5% on the session.
  • Qualigen Therapeutics QLGN stock drifted down 14.23% on Monday morning to hit a new 52-week low of $2.15.
  • Idera Pharmaceuticals IDRA stock dropped to a yearly low on Monday of $1.21. Shares traded down 3.57%.
  • Astrotech ASTC shares moved down 6.12% on Monday to hit a new 52-week low of $1.35, drifting down 6.12%.
  • Millendo Therapeutics MLND stock dropped to a yearly low on Monday of $1.12. Shares traded down 0.86%.

 

Benzinga will update traders on these companies going forward. If these companies break to a new level, Benzinga will be the first to report on it.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsIntraday UpdateMarketsMoversTrading Ideas52 Week Lows52-Week LowsBZI-52Weeks
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...